🔎 Trials Near Me

Akèy › Kansè kol › Virginia

Etid klinik pou Kansè kol nan Virginia

20 etid pou Kansè kol ap chèche patisipan nan sit nan Virginia.

Vil nan Virginia

Tèks ofisyèl etid la (Anglè)

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

  • Virginia Commonwealth University/ Massey Cancer Center, Richmond
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Fanm · Mizajou Sep 29, 2026 · NCT05051722

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • UVA Comprehensive Cancer Center, Charlottesville
  • University of Virginia, Charlottesville
  • UVA Health Cancer Care Pantops, Charlottesville
  • ak 1 plis
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT06952660

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)

  • University of Virginia Cancer Center ( Site 5044), Charlottesville
  • University of Virginia Cancer Center ( Site 6014), Charlottesville
  • Inova Schar Cancer Institute ( Site 5045), Fairfax
Ap rekriteFaz 3
Laj 18 ak plis · Fanm · Mizajou Sep 25, 2026 · NCT07216703

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05983432

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • NEXT Oncology, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07109726

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06293898

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

  • NEXT Virginia, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07227168

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

  • Normunity Investigational Site, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07182149

A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors

  • Clinical Trial Site, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07749586

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

  • Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT06330064

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • University of Virginia Comprehensive Cancer Center, Charlottesville
  • University of Virginia, Charlottesville
  • Inova Health System, Fairfax
  • ak 7 plis
Ap rekrite
Laj 18 ak plis · Fanm · Mizajou Jul 30, 2026 · NCT04831580

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  • NEXT Virginia, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT07524322

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

  • USO-Virginia Cancer Specialists, PC, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632

Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors

  • NEXT, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT06993844

Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women

  • ISA Associates, Arlington
Ap rekrite
Laj 21 a 65 · Fanm · Mizajou Apr 21, 2026 · NCT07011836

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

  • Dren Investigational Site, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jan 7, 2026 · NCT06999187

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 102, Fairfax
  • Research Site 112, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Nov 21, 2025 · NCT05914116

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Charlottesville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

A Study of NX-1607 in Adults With Advanced Malignancies

  • University of Virginia, Charlottesville
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT05107674

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.